TITLE

Contra Pfizer

AUTHOR(S)
Healy, David
PUB. DATE
November 2005
SOURCE
Ethical Human Psychology & Psychiatry;Fall/Winter2005, Vol. 7 Issue 3, p181
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Against a background of longstanding concerns that antidepressants may trigger suicidality, the Food and Drug Administration (FDA) in 2004 convened two committees to review the issues. Prior to the second meeting Pfizer posted an extensive ad hominem attack on me on FDA's website. There was no opportunity to post a response. This article covers the points made in response and sheds some light on pharmaceutical company handling of debates about adverse events.
ACCESSION #
25237119

 

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics